PT - JOURNAL ARTICLE AU - Zahinoor Ismail AU - Alexander McGirr AU - Sascha Gill AU - Sophie Hu AU - Nils D. Forkert AU - Eric E. Smith TI - Mild Behavioral Impairment and Subjective Cognitive Decline predict Mild Cognitive Impairment AID - 10.1101/2020.05.24.20112284 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.24.20112284 4099 - http://medrxiv.org/content/early/2020/05/25/2020.05.24.20112284.short 4100 - http://medrxiv.org/content/early/2020/05/25/2020.05.24.20112284.full AB - Objective Better methods for detecting preclinical neuropathological change are required for prevention of dementia. Mild behavioral impairment (MBI) and subjective cognitive decline (SCD) can represent neurobehavioral and neurocognitive axes of early stage neurodegenerative processes, which are represented in Stage 2 of the NIA-AA Alzheimer’s disease research framework. Both MBI and SCD may offer an opportunity for premorbid detection. We test the hypothesis that MBI and SCD confer additive risk for incident cognitive decline.Methods Participants were cognitively normal older adults followed up approximately annually at Alzheimer’s Disease Centers. Logistic regression was used to determine the relationship between baseline classification (MBI+, SCD+, neither (MBI-SCD-), or both (MBI+SCD+)) and cognitive decline, defined by Clinical Dementia Rating (CDR) total score, at 3 years.Results Of 2769 participants (mean age=76; 63% females), 1536 were MBI-SCD-, 254 MBI-SCD+, 743 MBI+SCD-, and 236 MBI+SCD+. At 3-years, 349 individuals (12.6%) developed cognitive decline to CDR>0. Compared to SCD-MBI-, we observed an ordinal progression in risk, with ORs [95% CI] as follows: 3.61 [2.42-5.38] for MBI-SCD+ (16.5% progression), 4.76 [3.57-6.34] for MBI+SCD-, (20.7% progression) and 8.15 [5.71-11.64] for MBI+SCD+ (30.9% progression).Conclusion MBI in older adults alone or in combination with SCD is associated with a higher risk of incident cognitive decline at 3 years. The highest rate of progression to MCI is observed in those with both MBI and SCD. Used in conjunction, MBI and SCD could be simple and scalable methods to identify patients at high risk for cognitive decline for prevention studies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementGrant support included the Alzheimer Society of Calgary via the Hotchkiss Brain Institute (Ismail). We also acknowledge the Mathison Centre for Mental Health Research & Education, and the Ron and Rene Ward Centre for Healthy Brain Aging for support. Dr. Ismail reports grants and personal fees from Janssen, and personal fees from Lundbeck and Otsuka, outside the submitted work; Dr. Smith reports personal fees from Alnylman Pharmaceuticals, personal fees from Portola Pharmaceuticals, personal fees from Biogen, outside the submitted work; no other authors have financial interests with commercial interests.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The NACC database itself is exempt from IRB review and approval because it does not involve human subjects, as defined by federal and state regulations. However, all contributing ADCs are required to obtain informed consent from their participants and maintain their own separate IRB review and approval from their institution prior to submitting data to NACC.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available upon request.